Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

Grazia Daniela Femminella; Eleni Frangou; Sharon B Love; Gail Busza; Clive Holmes; Craig Ritchie; Robert Lawrence; Brady McFarlane; George Tadros; Basil H Ridha; Carol Bannister; Zuzana Walker; Hilary Archer; Elizabeth Coulthard; Ben R Underwood; Aparna Prasanna; Paul Koranteng; Salman Karim; Kehinde Junaid; Bernadette McGuinness; Ramin Nilforooshan; Ajay Macharouthu; Andrew Donaldson; Simon Thacker; Gregor Russell; Naghma Malik; Vandana Mate; Lucy Knight; Sajeev Kshemendran; John Harrison; Christian Hölscher; David J Brooks; Anthony Peter Passmore; Clive Ballard; Paul Edison

doi:10.1186/s13063-020-04608-4

Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, Gail Busza, Clive Holmes, Craig Ritchie, Robert Lawrence, Brady McFarlane, George Tadros, Basil H Ridha, Carol Bannister, Zuzana Walker, Hilary Archer, Elizabeth Coulthard, Ben R Underwood, Aparna Prasanna, Paul Koranteng, Salman Karim, Kehinde Junaid, Bernadette McGuinnessRamin Nilforooshan, Ajay Macharouthu, Andrew Donaldson, Simon Thacker, Gregor Russell, Naghma Malik, Vandana Mate, Lucy Knight, Sajeev Kshemendran, John Harrison, Christian Hölscher, David J Brooks, Anthony Peter Passmore, Clive Ballard, Paul Edison^*

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal)

9 Citations (Scopus)

51 Downloads (Pure)

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Original language	English
Article number	660 (2020)
Number of pages	1
Journal	Trials
Volume	21
Issue number	1
DOIs	https://doi.org/10.1186/s13063-020-04608-4
Publication status	Published - 19 Jul 2020

Bibliographical note

The acceptance date for this record is provisional and based upon the month of publication for the article.

Access to Document

10.1186/s13063-020-04608-4

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via Springer Nature at https://doi.org/10.1186/s13063-020-04608-4. Please refer to any applicable terms of use of the publisher.
Final published version, 194 KBLicence: CC BY

Handle.net

Persistent link

Cite this

Femminella, G. D., Frangou, E., Love, S. B., Busza, G., Holmes, C., Ritchie, C., Lawrence, R., McFarlane, B., Tadros, G., Ridha, B. H., Bannister, C., Walker, Z., Archer, H., Coulthard, E., Underwood, B. R., Prasanna, A., Koranteng, P., Karim, S., Junaid, K., ... Edison, P. (2020). Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials, 21(1), Article 660 (2020) . https://doi.org/10.1186/s13063-020-04608-4

@article{12751cc2f0c24f12bea0ab8d1603095b,

title = "Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)",

abstract = "An amendment to this paper has been published and can be accessed via the original article.",

author = "Femminella, {Grazia Daniela} and Eleni Frangou and Love, {Sharon B} and Gail Busza and Clive Holmes and Craig Ritchie and Robert Lawrence and Brady McFarlane and George Tadros and Ridha, {Basil H} and Carol Bannister and Zuzana Walker and Hilary Archer and Elizabeth Coulthard and Underwood, {Ben R} and Aparna Prasanna and Paul Koranteng and Salman Karim and Kehinde Junaid and Bernadette McGuinness and Ramin Nilforooshan and Ajay Macharouthu and Andrew Donaldson and Simon Thacker and Gregor Russell and Naghma Malik and Vandana Mate and Lucy Knight and Sajeev Kshemendran and John Harrison and Christian H{\"o}lscher and Brooks, {David J} and Passmore, {Anthony Peter} and Clive Ballard and Paul Edison",

note = "The acceptance date for this record is provisional and based upon the month of publication for the article.",

year = "2020",

month = jul,

day = "19",

doi = "10.1186/s13063-020-04608-4",

language = "English",

volume = "21",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central",

number = "1",

}

Femminella, GD, Frangou, E, Love, SB, Busza, G, Holmes, C, Ritchie, C, Lawrence, R, McFarlane, B, Tadros, G, Ridha, BH, Bannister, C, Walker, Z, Archer, H, Coulthard, E, Underwood, BR, Prasanna, A, Koranteng, P, Karim, S, Junaid, K, McGuinness, B, Nilforooshan, R, Macharouthu, A, Donaldson, A, Thacker, S, Russell, G, Malik, N, Mate, V, Knight, L, Kshemendran, S, Harrison, J, Hölscher, C, Brooks, DJ, Passmore, AP, Ballard, C & Edison, P 2020, 'Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)', Trials, vol. 21, no. 1, 660 (2020) . https://doi.org/10.1186/s13063-020-04608-4

TY - JOUR

T1 - Correction to

T2 - Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

AU - Femminella, Grazia Daniela

AU - Frangou, Eleni

AU - Love, Sharon B

AU - Busza, Gail

AU - Holmes, Clive

AU - Ritchie, Craig

AU - Lawrence, Robert

AU - McFarlane, Brady

AU - Tadros, George

AU - Ridha, Basil H

AU - Bannister, Carol

AU - Walker, Zuzana

AU - Archer, Hilary

AU - Coulthard, Elizabeth

AU - Underwood, Ben R

AU - Prasanna, Aparna

AU - Koranteng, Paul

AU - Karim, Salman

AU - Junaid, Kehinde

AU - McGuinness, Bernadette

AU - Nilforooshan, Ramin

AU - Macharouthu, Ajay

AU - Donaldson, Andrew

AU - Thacker, Simon

AU - Russell, Gregor

AU - Malik, Naghma

AU - Mate, Vandana

AU - Knight, Lucy

AU - Kshemendran, Sajeev

AU - Harrison, John

AU - Hölscher, Christian

AU - Brooks, David J

AU - Passmore, Anthony Peter

AU - Ballard, Clive

AU - Edison, Paul

N1 - The acceptance date for this record is provisional and based upon the month of publication for the article.

PY - 2020/7/19

Y1 - 2020/7/19

N2 - An amendment to this paper has been published and can be accessed via the original article.

AB - An amendment to this paper has been published and can be accessed via the original article.

U2 - 10.1186/s13063-020-04608-4

DO - 10.1186/s13063-020-04608-4

M3 - Article (Academic Journal)

C2 - 32684162

SN - 1745-6215

VL - 21

JO - Trials

JF - Trials

IS - 1

M1 - 660 (2020)

ER -

Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)

Abstract

Bibliographical note

Access to Document

Handle.net

Fingerprint

Cite this